nodes	percent_of_prediction	percent_of_DWPC	metapath
Betahistine—Cutaneous hypersensitivity—Docetaxel—melanoma	0.0313	0.0554	CcSEcCtD
Betahistine—Digestion impaired—Temozolomide—melanoma	0.0172	0.0305	CcSEcCtD
Betahistine—Stevens-Johnson syndrome—Vemurafenib—melanoma	0.0125	0.0221	CcSEcCtD
Betahistine—Erythema multiforme—Vemurafenib—melanoma	0.0107	0.0189	CcSEcCtD
Betahistine—Dermatitis atopic—Docetaxel—melanoma	0.0103	0.0183	CcSEcCtD
Betahistine—Bronchospasm—Bleomycin—melanoma	0.0084	0.0149	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.00831	0.0147	CcSEcCtD
Betahistine—Anaphylactic shock—Vemurafenib—melanoma	0.00802	0.0142	CcSEcCtD
Betahistine—Nervous system disorder—Vemurafenib—melanoma	0.00787	0.0139	CcSEcCtD
Betahistine—Skin disorder—Vemurafenib—melanoma	0.00779	0.0138	CcSEcCtD
Betahistine—Abdominal distension—Temozolomide—melanoma	0.00726	0.0129	CcSEcCtD
Betahistine—Stevens-Johnson syndrome—Dactinomycin—melanoma	0.00704	0.0125	CcSEcCtD
Betahistine—Gastrointestinal disorder—Vemurafenib—melanoma	0.00692	0.0123	CcSEcCtD
Betahistine—Fatigue—Vemurafenib—melanoma	0.00691	0.0123	CcSEcCtD
Betahistine—Stevens-Johnson syndrome—Temozolomide—melanoma	0.00637	0.0113	CcSEcCtD
Betahistine—Erythema multiforme—Dactinomycin—melanoma	0.00603	0.0107	CcSEcCtD
Betahistine—Hallucination—Carmustine—melanoma	0.00594	0.0105	CcSEcCtD
Betahistine—Hypersensitivity—Vemurafenib—melanoma	0.00591	0.0105	CcSEcCtD
Betahistine—Asthenia—Vemurafenib—melanoma	0.00575	0.0102	CcSEcCtD
Betahistine—Hallucination—Temozolomide—melanoma	0.00574	0.0102	CcSEcCtD
Betahistine—Pruritus—Vemurafenib—melanoma	0.00567	0.0101	CcSEcCtD
Betahistine—Ill-defined disorder—Bleomycin—melanoma	0.00552	0.00979	CcSEcCtD
Betahistine—Diarrhoea—Vemurafenib—melanoma	0.00549	0.00972	CcSEcCtD
Betahistine—Erythema multiforme—Temozolomide—melanoma	0.00545	0.00967	CcSEcCtD
Betahistine—Malaise—Bleomycin—melanoma	0.00537	0.00951	CcSEcCtD
Betahistine—Dizziness—Vemurafenib—melanoma	0.0053	0.0094	CcSEcCtD
Betahistine—Immune system disorder—Temozolomide—melanoma	0.00521	0.00923	CcSEcCtD
Betahistine—Ill-defined disorder—Dactinomycin—melanoma	0.00515	0.00913	CcSEcCtD
Betahistine—Vomiting—Vemurafenib—melanoma	0.0051	0.00904	CcSEcCtD
Betahistine—Abdominal pain upper—Docetaxel—melanoma	0.00507	0.00898	CcSEcCtD
Betahistine—Orthostatic hypotension—Docetaxel—melanoma	0.00507	0.00898	CcSEcCtD
Betahistine—Rash—Vemurafenib—melanoma	0.00506	0.00896	CcSEcCtD
Betahistine—Dermatitis—Vemurafenib—melanoma	0.00505	0.00895	CcSEcCtD
Betahistine—Headache—Vemurafenib—melanoma	0.00502	0.0089	CcSEcCtD
Betahistine—Discomfort—Bleomycin—melanoma	0.00501	0.00887	CcSEcCtD
Betahistine—Malaise—Dactinomycin—melanoma	0.00501	0.00887	CcSEcCtD
Betahistine—Confusional state—Bleomycin—melanoma	0.0049	0.00868	CcSEcCtD
Betahistine—Anaphylactic shock—Bleomycin—melanoma	0.00486	0.00861	CcSEcCtD
Betahistine—Nausea—Vemurafenib—melanoma	0.00476	0.00844	CcSEcCtD
Betahistine—Bronchospasm—Docetaxel—melanoma	0.00471	0.00835	CcSEcCtD
Betahistine—Discomfort—Dactinomycin—melanoma	0.00467	0.00828	CcSEcCtD
Betahistine—Ill-defined disorder—Temozolomide—melanoma	0.00466	0.00826	CcSEcCtD
Betahistine—Angioedema—Temozolomide—melanoma	0.00459	0.00813	CcSEcCtD
Betahistine—Malaise—Temozolomide—melanoma	0.00453	0.00803	CcSEcCtD
Betahistine—Convulsion—Carmustine—melanoma	0.0045	0.00798	CcSEcCtD
Betahistine—Convulsion—Temozolomide—melanoma	0.00435	0.00771	CcSEcCtD
Betahistine—Dyspnoea—Bleomycin—melanoma	0.00433	0.00768	CcSEcCtD
Betahistine—Confusional state—Carmustine—melanoma	0.00428	0.00758	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.00425	0.00752	CcSEcCtD
Betahistine—Stevens-Johnson syndrome—Docetaxel—melanoma	0.00424	0.00751	CcSEcCtD
Betahistine—Discomfort—Temozolomide—melanoma	0.00422	0.00749	CcSEcCtD
Betahistine—Tachycardia—Carmustine—melanoma	0.00414	0.00733	CcSEcCtD
Betahistine—Confusional state—Temozolomide—melanoma	0.00413	0.00732	CcSEcCtD
Betahistine—Anaphylactic shock—Temozolomide—melanoma	0.0041	0.00726	CcSEcCtD
Betahistine—Nervous system disorder—Temozolomide—melanoma	0.00402	0.00712	CcSEcCtD
Betahistine—Feeling abnormal—Bleomycin—melanoma	0.004	0.0071	CcSEcCtD
Betahistine—Skin disorder—Temozolomide—melanoma	0.00398	0.00705	CcSEcCtD
Betahistine—Fatigue—Dactinomycin—melanoma	0.00391	0.00692	CcSEcCtD
Betahistine—Urticaria—Bleomycin—melanoma	0.00386	0.00684	CcSEcCtD
Betahistine—Dyspnoea—Carmustine—melanoma	0.00378	0.0067	CcSEcCtD
Betahistine—Somnolence—Carmustine—melanoma	0.00377	0.00668	CcSEcCtD
Betahistine—Feeling abnormal—Dactinomycin—melanoma	0.00373	0.00662	CcSEcCtD
Betahistine—Gastrointestinal disorder—Carmustine—melanoma	0.00366	0.00649	CcSEcCtD
Betahistine—Dyspnoea—Temozolomide—melanoma	0.00365	0.00648	CcSEcCtD
Betahistine—Somnolence—Temozolomide—melanoma	0.00364	0.00646	CcSEcCtD
Betahistine—Erythema multiforme—Docetaxel—melanoma	0.00363	0.00643	CcSEcCtD
Betahistine—Dyspepsia—Temozolomide—melanoma	0.00361	0.00639	CcSEcCtD
Betahistine—Hypersensitivity—Bleomycin—melanoma	0.00358	0.00634	CcSEcCtD
Betahistine—Gastrointestinal disorder—Temozolomide—melanoma	0.00354	0.00627	CcSEcCtD
Betahistine—Fatigue—Temozolomide—melanoma	0.00353	0.00626	CcSEcCtD
Betahistine—Feeling abnormal—Carmustine—melanoma	0.0035	0.00619	CcSEcCtD
Betahistine—Asthenia—Bleomycin—melanoma	0.00349	0.00618	CcSEcCtD
Betahistine—Immune system disorder—Docetaxel—melanoma	0.00347	0.00614	CcSEcCtD
Betahistine—Pruritus—Bleomycin—melanoma	0.00344	0.00609	CcSEcCtD
Betahistine—Feeling abnormal—Temozolomide—melanoma	0.00338	0.00598	CcSEcCtD
Betahistine—Hypersensitivity—Dactinomycin—melanoma	0.00334	0.00592	CcSEcCtD
Betahistine—Urticaria—Temozolomide—melanoma	0.00326	0.00577	CcSEcCtD
Betahistine—Asthenia—Dactinomycin—melanoma	0.00325	0.00576	CcSEcCtD
Betahistine—Hypersensitivity—Carmustine—melanoma	0.00312	0.00554	CcSEcCtD
Betahistine—Diarrhoea—Dactinomycin—melanoma	0.0031	0.00549	CcSEcCtD
Betahistine—Vomiting—Bleomycin—melanoma	0.00309	0.00547	CcSEcCtD
Betahistine—Rash—Bleomycin—melanoma	0.00306	0.00543	CcSEcCtD
Betahistine—Dermatitis—Bleomycin—melanoma	0.00306	0.00542	CcSEcCtD
Betahistine—Asthenia—Carmustine—melanoma	0.00304	0.00539	CcSEcCtD
Betahistine—Hypersensitivity—Temozolomide—melanoma	0.00302	0.00535	CcSEcCtD
Betahistine—Asthenia—Temozolomide—melanoma	0.00294	0.00521	CcSEcCtD
Betahistine—Diarrhoea—Carmustine—melanoma	0.0029	0.00514	CcSEcCtD
Betahistine—Pruritus—Temozolomide—melanoma	0.0029	0.00514	CcSEcCtD
Betahistine—Convulsion—Docetaxel—melanoma	0.00289	0.00513	CcSEcCtD
Betahistine—Nausea—Bleomycin—melanoma	0.00289	0.00511	CcSEcCtD
Betahistine—Vomiting—Dactinomycin—melanoma	0.00288	0.00511	CcSEcCtD
Betahistine—Rash—Dactinomycin—melanoma	0.00286	0.00506	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.00282	0.005	CcSEcCtD
Betahistine—Dizziness—Carmustine—melanoma	0.0028	0.00497	CcSEcCtD
Betahistine—Diarrhoea—Temozolomide—melanoma	0.0028	0.00497	CcSEcCtD
Betahistine—Confusional state—Docetaxel—melanoma	0.00275	0.00487	CcSEcCtD
Betahistine—Anaphylactic shock—Docetaxel—melanoma	0.00273	0.00483	CcSEcCtD
Betahistine—Dizziness—Temozolomide—melanoma	0.00271	0.0048	CcSEcCtD
Betahistine—Vomiting—Carmustine—melanoma	0.0027	0.00478	CcSEcCtD
Betahistine—Nausea—Dactinomycin—melanoma	0.00269	0.00477	CcSEcCtD
Betahistine—Rash—Carmustine—melanoma	0.00267	0.00474	CcSEcCtD
Betahistine—Nervous system disorder—Docetaxel—melanoma	0.00267	0.00474	CcSEcCtD
Betahistine—Dermatitis—Carmustine—melanoma	0.00267	0.00473	CcSEcCtD
Betahistine—Tachycardia—Docetaxel—melanoma	0.00266	0.00471	CcSEcCtD
Betahistine—Headache—Carmustine—melanoma	0.00266	0.00471	CcSEcCtD
Betahistine—Skin disorder—Docetaxel—melanoma	0.00265	0.00469	CcSEcCtD
Betahistine—Vomiting—Temozolomide—melanoma	0.00261	0.00462	CcSEcCtD
Betahistine—Rash—Temozolomide—melanoma	0.00258	0.00458	CcSEcCtD
Betahistine—Dermatitis—Temozolomide—melanoma	0.00258	0.00458	CcSEcCtD
Betahistine—Headache—Temozolomide—melanoma	0.00257	0.00455	CcSEcCtD
Betahistine—Nausea—Carmustine—melanoma	0.00252	0.00446	CcSEcCtD
Betahistine—Nausea—Temozolomide—melanoma	0.00243	0.00431	CcSEcCtD
Betahistine—Dyspnoea—Docetaxel—melanoma	0.00243	0.00431	CcSEcCtD
Betahistine—Somnolence—Docetaxel—melanoma	0.00242	0.00429	CcSEcCtD
Betahistine—Dyspepsia—Docetaxel—melanoma	0.0024	0.00425	CcSEcCtD
Betahistine—Gastrointestinal disorder—Docetaxel—melanoma	0.00235	0.00417	CcSEcCtD
Betahistine—Fatigue—Docetaxel—melanoma	0.00235	0.00416	CcSEcCtD
Betahistine—Feeling abnormal—Docetaxel—melanoma	0.00225	0.00398	CcSEcCtD
Betahistine—Hypersensitivity—Docetaxel—melanoma	0.00201	0.00356	CcSEcCtD
Betahistine—Asthenia—Docetaxel—melanoma	0.00196	0.00347	CcSEcCtD
Betahistine—Pruritus—Docetaxel—melanoma	0.00193	0.00342	CcSEcCtD
Betahistine—Diarrhoea—Docetaxel—melanoma	0.00187	0.0033	CcSEcCtD
Betahistine—Dizziness—Docetaxel—melanoma	0.0018	0.00319	CcSEcCtD
Betahistine—Vomiting—Docetaxel—melanoma	0.00173	0.00307	CcSEcCtD
Betahistine—Rash—Docetaxel—melanoma	0.00172	0.00305	CcSEcCtD
Betahistine—Dermatitis—Docetaxel—melanoma	0.00172	0.00304	CcSEcCtD
Betahistine—Headache—Docetaxel—melanoma	0.00171	0.00303	CcSEcCtD
Betahistine—Nausea—Docetaxel—melanoma	0.00162	0.00287	CcSEcCtD
Betahistine—HRH3—GPCR downstream signaling—PIK3CG—melanoma	0.000572	0.00131	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—TAS2R60—melanoma	0.000566	0.0013	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—CCR7—melanoma	0.000554	0.00127	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—GRM1—melanoma	0.000554	0.00127	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—KISS1—melanoma	0.00055	0.00126	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—HDAC2—melanoma	0.000545	0.00125	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—FOXO4—melanoma	0.000545	0.00125	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CXCR4—melanoma	0.000545	0.00125	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—GNAQ—melanoma	0.000539	0.00124	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—CXCR1—melanoma	0.000533	0.00122	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—MC1R—melanoma	0.000525	0.0012	CbGpPWpGaD
Betahistine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MAP2K1—melanoma	0.000525	0.0012	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—PIK3CG—melanoma	0.000519	0.00119	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—SYK—melanoma	0.000507	0.00116	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—RHOB—melanoma	0.000504	0.00116	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—CCR7—melanoma	0.000503	0.00116	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—GRM1—melanoma	0.000503	0.00116	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—PIK3CD—melanoma	0.000503	0.00115	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—ITGAV—melanoma	0.000498	0.00114	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—AKT3—melanoma	0.000498	0.00114	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—NGFR—melanoma	0.000498	0.00114	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—SOCS1—melanoma	0.000461	0.00106	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—MAP2K1—melanoma	0.00046	0.00105	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—S100B—melanoma	0.00046	0.00105	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—CXCR2—melanoma	0.000459	0.00105	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—RHOB—melanoma	0.000458	0.00105	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—PIK3CD—melanoma	0.000457	0.00105	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—EDN1—melanoma	0.000455	0.00105	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—RAC2—melanoma	0.000452	0.00104	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—ERBB4—melanoma	0.000439	0.00101	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—PIK3CB—melanoma	0.000438	0.00101	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CDKN2B—melanoma	0.000436	0.001	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CXCL1—melanoma	0.000429	0.000984	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PLCB4—melanoma	0.000429	0.000984	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CD86—melanoma	0.000421	0.000967	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—CXCL8—melanoma	0.000421	0.000967	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—EDN1—melanoma	0.000418	0.00096	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—CXCR2—melanoma	0.000417	0.000957	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—RAC2—melanoma	0.00041	0.000942	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CSF2—melanoma	0.000409	0.000938	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—FGF1—melanoma	0.000409	0.000938	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—WNT5A—melanoma	0.000404	0.000927	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—TRRAP—melanoma	0.000403	0.000926	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CUL3—melanoma	0.000403	0.000926	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—IL2—melanoma	0.000402	0.000924	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—E2F1—melanoma	0.0004	0.000918	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—PIK3CB—melanoma	0.000398	0.000913	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—PDGFRA—melanoma	0.000396	0.000908	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—AKR1B10—melanoma	0.000392	0.0009	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—PRKCA—melanoma	0.000392	0.000899	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—ITGB3—melanoma	0.000392	0.000899	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—F2R—melanoma	0.00039	0.000896	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—SPP1—melanoma	0.000384	0.000882	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—MAP2K2—melanoma	0.000383	0.000879	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—CXCL8—melanoma	0.000382	0.000878	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—EDNRB—melanoma	0.000378	0.000868	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—IL2—melanoma	0.000365	0.000839	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—F2RL1—melanoma	0.000365	0.000837	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—TERT—melanoma	0.000364	0.000836	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—RAC1—melanoma	0.000363	0.000834	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—GNA11—melanoma	0.000357	0.00082	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—GAB2—melanoma	0.000357	0.00082	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—F2R—melanoma	0.000355	0.000814	CbGpPWpGaD
Betahistine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—melanoma	0.00035	0.000804	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—HIF1A—melanoma	0.000348	0.000799	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—EDNRB—melanoma	0.000343	0.000788	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—GRM3—melanoma	0.000343	0.000787	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—CXCR4—melanoma	0.000336	0.000771	CbGpPWpGaD
Betahistine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—melanoma	0.000335	0.00077	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—KDR—melanoma	0.000333	0.000765	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—GNAQ—melanoma	0.000332	0.000762	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—KISS1—melanoma	0.000325	0.000746	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—GAB2—melanoma	0.000324	0.000744	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—GNA11—melanoma	0.000324	0.000744	CbGpPWpGaD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—melanoma	0.000323	0.000742	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—FN1—melanoma	0.000321	0.000736	CbGpPWpGaD
Betahistine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—melanoma	0.000319	0.000733	CbGpPWpGaD
Betahistine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—melanoma	0.000319	0.000732	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—SKI—melanoma	0.000315	0.000723	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CXCR1—melanoma	0.000315	0.000723	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—NOTCH1—melanoma	0.000314	0.00072	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—MC1R—melanoma	0.00031	0.000712	CbGpPWpGaD
Betahistine—HRH1—G alpha (q) signalling events—PIK3CA—melanoma	0.00031	0.000711	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CD80—melanoma	0.000307	0.000706	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—APC—melanoma	0.000307	0.000704	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—PIK3CG—melanoma	0.000307	0.000704	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—KIT—melanoma	0.000307	0.000704	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—NRAS—melanoma	0.000307	0.000704	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—AKT3—melanoma	0.000306	0.000703	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—CXCR4—melanoma	0.000305	0.0007	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—EGF—melanoma	0.000303	0.000696	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—GNAQ—melanoma	0.000301	0.000692	CbGpPWpGaD
Betahistine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—melanoma	0.000301	0.000692	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—GRM1—melanoma	0.000297	0.000682	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CCR7—melanoma	0.000297	0.000682	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—MAPK3—melanoma	0.000294	0.000674	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—SUFU—melanoma	0.00029	0.000665	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—BRAF—melanoma	0.000288	0.000662	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—IGF1—melanoma	0.000281	0.000645	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—MAPK1—melanoma	0.00028	0.000642	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—EGFR—melanoma	0.00028	0.000642	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—AKT3—melanoma	0.000278	0.000639	CbGpPWpGaD
Betahistine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—melanoma	0.000277	0.000636	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—MAP2K1—melanoma	0.000271	0.000623	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—RHOB—melanoma	0.00027	0.000621	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—BCL2L11—melanoma	0.00027	0.000621	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—PIK3CD—melanoma	0.00027	0.000619	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—PIK3CA—melanoma	0.000267	0.000613	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—KRAS—melanoma	0.000264	0.000606	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—HDAC6—melanoma	0.00026	0.000596	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—FGF2—melanoma	0.000258	0.000593	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—EDN1—melanoma	0.000257	0.000591	CbGpPWpGaD
Betahistine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—melanoma	0.000256	0.000588	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—CSF2—melanoma	0.000252	0.000578	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CXCR2—melanoma	0.000246	0.000565	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—CXCL8—melanoma	0.000246	0.000565	CbGpPWpGaD
Betahistine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—melanoma	0.000245	0.000563	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—PIK3CA—melanoma	0.000243	0.000557	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—RAC2—melanoma	0.000242	0.000556	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—MDM2—melanoma	0.000242	0.000555	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—PRKCA—melanoma	0.000241	0.000554	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—WNT5A—melanoma	0.000239	0.000548	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—VEGFC—melanoma	0.000239	0.000548	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—ERBB2—melanoma	0.000238	0.000547	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—PIK3CB—melanoma	0.000235	0.00054	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—EDN1—melanoma	0.000234	0.000537	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—CSF2—melanoma	0.000228	0.000524	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CXCL8—melanoma	0.000226	0.000519	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—HRAS—melanoma	0.000224	0.000515	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—RAC1—melanoma	0.000224	0.000513	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CDKN1B—melanoma	0.000221	0.000506	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—PRKCA—melanoma	0.000219	0.000503	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—AKT1—melanoma	0.000218	0.000501	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CASP3—melanoma	0.000216	0.000496	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—IL2—melanoma	0.000216	0.000496	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—IL6—melanoma	0.000215	0.000493	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—MAP2K2—melanoma	0.000214	0.000492	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CCND1—melanoma	0.00021	0.000483	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—F2R—melanoma	0.000209	0.000481	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CTNNB1—melanoma	0.000208	0.000478	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—MMP9—melanoma	0.000204	0.000469	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CDKN1A—melanoma	0.000204	0.000467	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—PTEN—melanoma	0.000203	0.000466	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—RAC1—melanoma	0.000203	0.000466	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—EDNRB—melanoma	0.000203	0.000466	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—NFKB1—melanoma	0.000202	0.000464	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—AKT1—melanoma	0.000198	0.000455	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PTK2B—melanoma	0.000197	0.000452	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—GNA11—melanoma	0.000192	0.00044	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—GAB2—melanoma	0.000192	0.00044	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—FLT1—melanoma	0.000191	0.000438	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—PIK3CG—melanoma	0.000189	0.000434	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—VEGFA—melanoma	0.000183	0.000421	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—STAT3—melanoma	0.000182	0.000417	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—NRAS—melanoma	0.000181	0.000416	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—HDAC2—melanoma	0.00018	0.000413	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—FOXO4—melanoma	0.00018	0.000413	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CXCR4—melanoma	0.00018	0.000413	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—GNAQ—melanoma	0.000178	0.000409	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—MAPK3—melanoma	0.000174	0.000398	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—PIK3CG—melanoma	0.000172	0.000394	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—MYC—melanoma	0.000169	0.000388	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—SYK—melanoma	0.000167	0.000384	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—PIK3CD—melanoma	0.000166	0.000381	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—MAPK1—melanoma	0.000165	0.000379	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—EGFR—melanoma	0.000165	0.000379	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—ITGAV—melanoma	0.000164	0.000377	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—NGFR—melanoma	0.000164	0.000377	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—AKT3—melanoma	0.000164	0.000377	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—KRAS—melanoma	0.000156	0.000358	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—SOCS1—melanoma	0.000152	0.000349	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—MAP2K1—melanoma	0.000152	0.000349	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—S100B—melanoma	0.000152	0.000348	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—PIK3CD—melanoma	0.000151	0.000346	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—ERBB4—melanoma	0.000145	0.000333	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—PIK3CB—melanoma	0.000145	0.000332	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CDKN2B—melanoma	0.000144	0.00033	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—PIK3CA—melanoma	0.000143	0.000329	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CD86—melanoma	0.000139	0.000319	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—CXCL8—melanoma	0.000139	0.000319	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—TP53—melanoma	0.000139	0.000318	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—EDN1—melanoma	0.000138	0.000317	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CSF2—melanoma	0.000135	0.00031	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—FGF1—melanoma	0.000135	0.00031	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—IL2—melanoma	0.000133	0.000305	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—HRAS—melanoma	0.000133	0.000304	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—E2F1—melanoma	0.000132	0.000303	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—PIK3CB—melanoma	0.000131	0.000302	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PDGFRA—melanoma	0.000131	0.0003	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—ITGB3—melanoma	0.000129	0.000297	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PRKCA—melanoma	0.000129	0.000297	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—IL6—melanoma	0.000127	0.000291	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—SPP1—melanoma	0.000127	0.000291	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—MAP2K2—melanoma	0.000126	0.00029	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—CXCL8—melanoma	0.000126	0.00029	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—IL2—melanoma	0.000121	0.000277	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—TERT—melanoma	0.00012	0.000276	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—RAC1—melanoma	0.00012	0.000275	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—AKT1—melanoma	0.000117	0.000269	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—HIF1A—melanoma	0.000115	0.000264	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—KDR—melanoma	0.00011	0.000253	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—FN1—melanoma	0.000106	0.000243	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—NOTCH1—melanoma	0.000104	0.000238	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CD80—melanoma	0.000102	0.000233	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PIK3CG—melanoma	0.000101	0.000233	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—APC—melanoma	0.000101	0.000233	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—KIT—melanoma	0.000101	0.000233	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—NRAS—melanoma	0.000101	0.000233	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—EGF—melanoma	0.0001	0.00023	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—MAPK3—melanoma	9.71e-05	0.000223	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—BRAF—melanoma	9.53e-05	0.000219	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—IGF1—melanoma	9.28e-05	0.000213	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—MAPK1—melanoma	9.24e-05	0.000212	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—EGFR—melanoma	9.23e-05	0.000212	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—MAP2K1—melanoma	8.97e-05	0.000206	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PIK3CD—melanoma	8.91e-05	0.000205	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—PIK3CA—melanoma	8.83e-05	0.000203	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—KRAS—melanoma	8.72e-05	0.0002	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—FGF2—melanoma	8.53e-05	0.000196	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—PIK3CA—melanoma	8.01e-05	0.000184	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—MDM2—melanoma	7.98e-05	0.000183	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—ERBB2—melanoma	7.87e-05	0.000181	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PIK3CB—melanoma	7.77e-05	0.000178	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CXCL8—melanoma	7.46e-05	0.000171	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—HRAS—melanoma	7.41e-05	0.00017	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CDKN1B—melanoma	7.29e-05	0.000167	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—AKT1—melanoma	7.21e-05	0.000165	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CASP3—melanoma	7.14e-05	0.000164	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—IL2—melanoma	7.13e-05	0.000164	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—IL6—melanoma	7.1e-05	0.000163	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CCND1—melanoma	6.95e-05	0.00016	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CTNNB1—melanoma	6.89e-05	0.000158	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—MMP9—melanoma	6.75e-05	0.000155	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CDKN1A—melanoma	6.73e-05	0.000154	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PTEN—melanoma	6.71e-05	0.000154	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—NFKB1—melanoma	6.68e-05	0.000153	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—AKT1—melanoma	6.55e-05	0.00015	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—VEGFA—melanoma	6.06e-05	0.000139	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—STAT3—melanoma	6e-05	0.000138	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—NRAS—melanoma	5.99e-05	0.000137	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—MAPK3—melanoma	5.73e-05	0.000132	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—MYC—melanoma	5.58e-05	0.000128	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—MAPK1—melanoma	5.46e-05	0.000125	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—EGFR—melanoma	5.45e-05	0.000125	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—KRAS—melanoma	5.15e-05	0.000118	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PIK3CA—melanoma	4.73e-05	0.000109	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—TP53—melanoma	4.58e-05	0.000105	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—HRAS—melanoma	4.38e-05	0.000101	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—IL6—melanoma	4.19e-05	9.62e-05	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—AKT1—melanoma	3.87e-05	8.88e-05	CbGpPWpGaD
